Skip to content

PuraPly Micronized Wound Matrix (PuraPly MZ) 515-061Recalls & reported problems

Organogenesis Inc. · PuraPly® Micronized Wound Matrix (PuraPly® MZ) consists of micronized porcine collagen intended for the management of wounds. PuraPly® Micronized Wound Matrix is supplied as a dry powder of particle size of less than or equal to 1000. The device is sterile and packaged in a vial sealed in a single pouch. · Class U

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00618474000404), received between May 23, 2025 and May 23, 2025 — classified as 1 injury.

The most frequently reported specific device problem is “Insufficient Device Problem Information” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 1 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Insufficient Device Problem Information1

Patient problems

  • Post Operative Wound Infection1
  • Seroma1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryMay 23, 2025Insufficient Device Problem Information; Insufficient Device Problem Information

    EVENT DESCRIPTION: PHYSICIAN USED PURAPLY MZ IN A SURGICAL WOUND, AND THAT SURGICAL WOUND FORMED A SEROMA AND SUBSEQUENTLY BECAME INFECTED. REPORT SUMMARY: THIS REPORT IS BASED ON INFORMATION PROVIDED BY (B)(4), DISTRIBUTOR REPRESENTATIVE, WHO RELAYED RESPONSES FROM DR.(B)(6) VIA EMAIL, AND ALL AVAILABLE DOCUMENTATION. DURING A GENERAL DISCUSSION REGARDING ORGANOGENESIS PRODUCTS, (B)(4), EXECUTIVE DIRECTOR, ORTHOPEDIC BIOLOGICS AT ORGANOGENESIS, WAS INFORMED OF AN EVENT INVOLVING THE USE OF PURAPLY MZ. THE EVENT INVOLVED POSTOPERATIVE SEROMA FORMATION AT THE SURGICAL SITE, WHICH SUBSEQUENTLY BECAME INFECTED AND NECESSITATED A RETURN TO THE OPERATING ROOM (OR) FOR DEBRIDEMENT AND WASHOUT. THE COMPLAINT ABOUT THE EVENT WAS NOT INITIATED AT THE REQUEST OF THE PHYSICIAN. THE PATIENT, RR, A 74-YEAR-OLD FEMALE WITH NO SIGNIFICANT MEDICAL OR SURGICAL HISTORY AND KNOWN ALLERGY TO CODEINE, UNDERWENT SURGICAL INCISION OF A 6 CM RIGHT LATERAL KNEE LIPOMA ON (B)(6) 2025. NO BONE OR TENDON EXPOSURE WAS NOTED DURING THE PROCEDURE. PURAPLY MZ (LOT # MZ240516.1.1B) WAS APPLIED TO THE TISSUE OF THE SURGICAL SITE AND SURGICAL INCISION TO MANAGE THE SURGICAL WOUND. NO OTHER WOUND CARE PRODUCTS WERE U

    Patient problems: Post Operative Wound Infection; Seroma

    MAUDE report 22078753 ↗

Other Wound Dressing With Animal-Derived Material(S) devices

All Wound Dressing With Animal-Derived Material(S) devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page